Literature DB >> 3088120

Quantitation of monoclonal immunoglobulins by immuno-isoelectric focusing and its application for monitoring secretory B cell neoplasia.

D Sinclair, D M Parrott, D I Stott.   

Abstract

A scheme for quantitation of serum and urinary paraproteins is described using isoelectric focusing and scanning densitometry. Paraproteins could be quantified using this system when present at concentrations ranging from 1 mg/ml to 26 mg/ml, depending on the immunoglobulin class. The relevance of these results to monitoring secretory B cell neoplasia and the distinction between monoclonal gammopathy of undetermined significance and myeloma is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088120     DOI: 10.1016/0022-1759(86)90082-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

2.  Homogeneous immunoglobulins in the sera of lung carcinoma patients receiving cytotoxic chemotherapy--detection with the use of isoelectric focusing and immunoblotting.

Authors:  H Haas; A Lange; M Schlaak
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

3.  Do infections induce monoclonal immunoglobulin components?

Authors:  H Haas; S Anders; G W Bornkamm; E Mannweiler; H Schmitz; J Radl; M Schlaak
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

4.  A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc).

Authors:  R Hoffmann; A Braun; H Cleve
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

Review 5.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.